Kala Pharmaceuticals, Inc. KALA · Stock Open Kala Pharmaceuticals, Inc. in new tab
Kala Pharmaceuticals, Inc. Analysis (KALA)
Is Kala Pharmaceuticals, Inc. a good investment? Kala Pharmaceuticals, Inc. (KALA) is currently trading at 0.7830 USD.
Earnings Schedule: Kala Pharmaceuticals, Inc. is expected to release its next earnings report on Aug. 6, 2026. The market consensus estimate for Forward EPS is -6.67.
Investor FAQ
Does Kala Pharmaceuticals, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Kala Pharmaceuticals, Inc.?
Kala Pharmaceuticals, Inc. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be Aug. 6, 2026. The company currently has a trailing EPS of -102.01.
Company Profile
KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company develops Researgency, an agentic AI research platform for private enterprise AI deployment. Its platform intends to utilize the KPI-012 clinical development dataset as a proof-of-concept validation environment, as well as the mesenchymal stem cell secretome (MSC-S) and persistent corneal epithelial defects (PCED) research for agentic workflows on trial data. The company serves biotechnology and pharmaceutical companies. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.
| Split Date | Split Ratio to 1 |
|---|---|
| Oct. 21, 2022 | 0.020000 |
| May 11, 2026 | 0.020000 |
Community Discussion